Key facts
- It has raised $200.1M across 3 recorded rounds; the latest was Later Stage VC ($95.0M) in Dec 2024.
- Notable investors include Y Combinator, Andreessen Horowitz, General Catalyst, BoxGroup, Liquid 2 Ventures — 27 tracked in total.
- H1 Insights has filed 4 Form Ds with the SEC since 2020, most recently Dec 2024 ($95.0M sold to 68 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for H1 Insights
Funding rounds
3 roundsAbout H1 Insights
Operator of a healthcare data analytics platform intended to assist companies in making informed scientific decisions. The company's platform specializes in providing real-time data to support the end-to-end therapeutic development process from fundraising to product development to product launch, enabling the healthcare industry, organizations and professionals to have on-demand, live insights from across the data universe to accelerate the discovery and development of therapies to fight diseases.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2017
- Employees
- 465
- Website
- h1.co/
- Ownership
- Privately Held (backing)
H1 Insights doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in H1 Insights shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on H1 Insights in its N-PORT filings yet. We sweep new filings monthly.